Primary information |
---|
sequence ID | Seq_7481 |
Peptide sequence | SPMYSIITPNILR |
CancerPDF_ID | CancerPDF_ID1467, CancerPDF_ID1522, CancerPDF_ID2690, CancerPDF_ID11072, |
PMID | 21136997,21136997,21136997,27043541 |
Protein Name | Complement C3,Complement C3,Complement C3,CO3_HUMAN |
UniprotKB Entry Name | CO3_HUMAN,CO3_HUMAN,CO3_HUMAN,CO3_HUMAN |
Fluid | Serum,Serum,Plasma,Serum |
M/Z | 1503.81194,1519.80685,1503.8119,1520.8456 |
Charge | 1,1,1,NA |
Mass (in Da) | NA,NA,NA,NA |
fdr | NA,NA,NA,NA |
Profiling Technique | LC-MS,LC-MS,LC-MS,MALDI-TOF |
Peptide Identification technique | LC-MS-MS/MS,LC-MS-MS/MS,LC-MS-MS/MS,LC-MALDI-TOF/TOF-MS/MS |
Quantification Technique | LC-ESI-MS,LC-ESI-MS,LC-ESI-MS,NA |
Labelled/Label Free | Label Free,Label Free,Label Free,Label Free |
FDR | NA,NA,NA,NA |
CancerPDF_ID | CancerPDF_ID1467, CancerPDF_ID1522, CancerPDF_ID2690, CancerPDF_ID11072, |
p-Value | NA,NA,NA,NA |
Software | MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT |
Length | 13,13,13,13 |
Cancer Type | Colorectal cancer,Colorectal cancer,Normal,Non-small cell lung cancer (NSCLC) |
Database | SwissProt Database,SwissProt Database,SwissProt Database,SwissProt Database |
Modification | NA,Oxidation of Met,NA,phosphorylation |
Number of Patients | 30 patients and 30 healthy controls,30 patients and 30 healthy controls,27 healthy individuals,477 patients and healthy controls |
Regulation | NA,NA,NA,Differentially expressed between cancer vs normal |
Validation | Leave One out Cross validation,Leave One out Cross validation,Leave One out Cross validation,external cross validation done |
Sensitivity | NA,NA,NA,NA |
Specificity | NA,NA,NA,NA |
Accuracy | NA,NA,NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | 153006 |